<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02385903</url>
  </required_header>
  <id_info>
    <org_study_id>8546</org_study_id>
    <nct_id>NCT02385903</nct_id>
  </id_info>
  <brief_title>Randomized Controlled Trial on the Use of Flammacerium in Necrotic Arterial Wounds of the Lower Limb Versus Standard Treatment</brief_title>
  <acronym>Flammac√©rium</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rangueil Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beziers Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ischemia of an area may lead to a necrotic wound. In lower limb, it especially happens in
      diabetic or artheriopatic patients. It can lead to an amputation need. Revascularization
      procedure cannot be provide in all cases. Flammacerium, by a crust training and its
      anti-inflammatory effect, could stabilize necrosis extension, avoid bacterial contamination
      and then improve some incapacitating symptoms like odor or pain. This product may allow to
      delay amputation ruling for patients on who this procedure is unsafe. During 6 months, the
      investigators evaluate Flammacerium against standard dressing procedure in necrotic wound of
      the lower limb in patients where no revascularization can be provide. The investigators
      observed its effect on amputation need, symptoms as pain, infection, wound aspect evolution,
      wound size decrease.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Decision of the Independent Review Committee
  </why_stopped>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amputation rate</measure>
    <time_frame>6 months</time_frame>
    <description>Level of amputation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Infection rate</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound size</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain during dressing (VAS)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">55</enrollment>
  <condition>Ischemic Wound of the Lower Limb</condition>
  <condition>Necrotic Arterial Wounds</condition>
  <arm_group>
    <arm_group_label>Standard dressing procedure</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>One arm receive standard dressing procedure according to the wound</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Flammacerium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Necrosis covering with Flammacerium 3 mm thick each day during one week then one day on two.
On each dressing, remove excess and add flammacerium. Not to remove crust forming until eliminating furrow appears.
Cover Flammacerium by compress.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Flammacerium</intervention_name>
    <arm_group_label>Flammacerium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard dressing procedure</intervention_name>
    <arm_group_label>Standard dressing procedure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ischemic wound of the lower limb

          -  Minimum 50% necrosis

          -  Arteriopathy with ABI&lt;0.7 or &gt;1.3 with radiographic examinations

          -  No revascularisation procedure possible for any reasons

          -  No urgent amputation need

          -  Amputation considered in a short term

          -  Non life-threatened patients

        Exclusion Criteria:

          -  Sulphonamide hypersensibility

          -  Propyleneglycols hypersensibility

          -  Enzyme glucose deshydrogenase deficiencies

          -  Others studies participation

          -  Tutorship or curatoship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Wound healing Department</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2015</study_first_submitted>
  <study_first_submitted_qc>March 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 11, 2015</study_first_posted>
  <last_update_submitted>November 30, 2016</last_update_submitted>
  <last_update_submitted_qc>November 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Flammacerium</keyword>
  <keyword>Ischemic wound</keyword>
  <keyword>Lower limb</keyword>
  <keyword>Arteriopathy</keyword>
  <keyword>Amputation</keyword>
  <keyword>Dressing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Necrosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Silver Sulfadiazine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

